Traveller vaccination influenza: Difference between revisions
Created page with "__NOTOC__ {{Traveller vaccination human papillomavirus}} {{CMG}};{{AE}}{{MehdiP}} ==Overview== ==Disease cause== ==Transmission== ==Nature of the disease== ==Geographical..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Traveller vaccination | {{Traveller vaccination influenza}} | ||
{{CMG}};{{AE}}{{MehdiP}} | {{CMG}};{{AE}}{{MehdiP}} | ||
==Overview== | ==Overview== | ||
Protection against seasonal influenza is not specific to the needs of most travellers. During the influenza season, travellers should be offered vaccination against influenza according to national | |||
recommendations. | |||
==Disease cause== | ==Disease cause== | ||
Influenza viruses of types A and B. Type A viruses causing seasonal epidemics belong to subtypes H1, H2, or H3, and N1 or N2. More than one subtype of influenza A virus may circulate in the community during a season. Subtle genotypic variation may also be demonstrated among strains of influenza B. | |||
==Transmission== | ==Transmission== | ||
Airborne (droplets) and by direct contact. | |||
==Nature of the disease== | ==Nature of the disease== | ||
Acute respiratory infection, mostly mild, but occasionally severe with high fever, sore throat, cough and aches. Complications include viral pneumonitis and secondary infections such as bacterial pneumonia. Influenza is most severe in elderly people, pregnant women, young children and immunocompromised individuals. | |||
==Geographical distribution== | ==Geographical distribution== | ||
Worldwide. In the northern hemisphere from November to April; in the southern hemisphere from April to September. In tropical areas there is no clear seasonal pattern | |||
==Risk for travellers== | ==Risk for travellers== | ||
Travellers are not a particular risk group for influenza, but in some countries appropriate health care may be unavailable or hard to access for non-residents in case of severe disease. | |||
==Vaccine== | ==Vaccine== | ||
Influenza vaccines are either inactivated or live attenuated. | |||
== | *Inactivated vaccines are used for children aged more than 6 months, pregnant women, persons with high-risk medical conditions and the elderly. | ||
*Healthy non-pregnant individuals aged 2-49 years may alternatively receive live attenuated influenza vaccines. | |||
prevailing influenza strains in the northern and southern hemispheres may differ significantly, the composition of the influenza vaccine is different for each hemisphere and is specified at different times in the year, just before the start of the influenza season in each. | |||
==Contraindications== | |||
Vaccination is contraindicated in case of severe egg allergy, including anaphylactic reaction. | |||
Revision as of 15:42, 20 April 2017
Template:Traveller vaccination influenza Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Protection against seasonal influenza is not specific to the needs of most travellers. During the influenza season, travellers should be offered vaccination against influenza according to national recommendations.
Disease cause
Influenza viruses of types A and B. Type A viruses causing seasonal epidemics belong to subtypes H1, H2, or H3, and N1 or N2. More than one subtype of influenza A virus may circulate in the community during a season. Subtle genotypic variation may also be demonstrated among strains of influenza B.
Transmission
Airborne (droplets) and by direct contact.
Nature of the disease
Acute respiratory infection, mostly mild, but occasionally severe with high fever, sore throat, cough and aches. Complications include viral pneumonitis and secondary infections such as bacterial pneumonia. Influenza is most severe in elderly people, pregnant women, young children and immunocompromised individuals.
Geographical distribution
Worldwide. In the northern hemisphere from November to April; in the southern hemisphere from April to September. In tropical areas there is no clear seasonal pattern
Risk for travellers
Travellers are not a particular risk group for influenza, but in some countries appropriate health care may be unavailable or hard to access for non-residents in case of severe disease.
Vaccine
Influenza vaccines are either inactivated or live attenuated.
- Inactivated vaccines are used for children aged more than 6 months, pregnant women, persons with high-risk medical conditions and the elderly.
- Healthy non-pregnant individuals aged 2-49 years may alternatively receive live attenuated influenza vaccines.
prevailing influenza strains in the northern and southern hemispheres may differ significantly, the composition of the influenza vaccine is different for each hemisphere and is specified at different times in the year, just before the start of the influenza season in each.
Contraindications
Vaccination is contraindicated in case of severe egg allergy, including anaphylactic reaction.